Are we meeting the american diabetes association goals for HIV-infected patients with diabetes mellitus?

Clinical Infectious Diseases

Volumn 49, Issue 5, 2009, Pages 799-802

  Adeyemi, Oluwatoyin ^a,b   Vibhakar, Sonia ^a   Max, Blaka ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HIV INFECTIONS; HUMANS; LIPIDS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; UNITED STATES;

EID: 70149088418     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605286     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general informtation and national estimates on diabetes in the United States, 2007. Available at: http://www.cdc.gov/diabetes/. Accessed 16 July 2009.
2. Wand H, Calmy A, Carey DL, et al. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 2007; 21: 2445-2453 (Pubitemid 350145176)
3. Justman JE, Benning L, Danoff A, et al. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 2003; 32: 298-302. (Pubitemid 36331702)
4. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study. Arch Intern Med 2005; 165: 1179-1184 (Pubitemid 40720744)
5. De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008; 31: 1224-1229
6. Bury JE, Stroup JS, Stephens JR, Baker DL. Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus. Proc (Bayl Univ Med Cent) 2007; 20: 118-123
7. American Diabetes Association. Standards of medical care in diabetes- 2008. Diabetes Care 2008; 31 (Suppl 1): S12-54.
8. Benoit SR, Fleming R, Philis-Tsimikas A, et al. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health 2005; 5: 36-42. (Pubitemid 40923604)
9. Putzer G, Roetzheim R, Ramirez AM, et al. Compliance with recommendations for lipid management among patients with type 2 diabetes in an academic family practice. J Am Board Fara Pract 2004; 17: 101-107
10. Dube MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Diseases Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003; 37: 613-627
11. Gerber JG, Kitch D, Fichtenbaum C, et al. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. J Acquir Immune Defic Syndr 2008; 47: 459-466
12. Aberg JA, Zackin RA, Brobst SW, et al. A. randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Res Hum Retroviruses 2005; 21: 757-767
13. Tebas P. Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention and treatment options. J Acquir Immune Defic Syndr 2008; 49(Suppl 2): S86-92.
14. Ferrera A, Mangione C, Kim C, et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes. Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2008; 31: 69-74.
15. Gregg EW, Gu Q, Cheng YJ, et al. Mortality trends in men and women with diabetes, 1971-2000. Ann Intern Med 2007; 147: 149-155